Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CANAKINUMAB for Acromegaly: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 17 adverse event reports in the FDA FAERS database where CANAKINUMAB was used for Acromegaly.

Most Reported Side Effects for CANAKINUMAB

Side Effect Reports % Deaths Hosp.
Pyrexia 1,327 12.7% 33 450
Inappropriate schedule of drug administration 1,238 11.8% 2 26
Drug ineffective 1,078 10.3% 93 400
Inappropriate schedule of product administration 944 9.0% 7 97
Pain 858 8.2% 89 383
Condition aggravated 771 7.4% 14 182
Malaise 684 6.5% 11 139
Off label use 557 5.3% 97 299
Arthralgia 555 5.3% 5 146
Rash 505 4.8% 6 134
Incorrect dose administered 497 4.8% 1 32
Joint swelling 436 4.2% 83 289
Pneumonia 388 3.7% 51 243
Headache 379 3.6% 8 124
Fatigue 361 3.5% 4 104

Other Indications for CANAKINUMAB

Product used for unknown indication (2,800) Still's disease (1,847) Cryopyrin associated periodic syndrome (1,258) Juvenile idiopathic arthritis (980) Pyrexia (599) Cardiovascular event prophylaxis (560) Familial mediterranean fever (479) Rheumatoid arthritis (399) Systemic lupus erythematosus (282) Muckle-wells syndrome (236)

Other Drugs Used for Acromegaly

OCTREOTIDE (3,068) LANREOTIDE (1,956) PEGVISOMANT (1,911) PASIREOTIDE (737) CABERGOLINE (87) SANDOSTATIN LAR (86) SOMAVERT (42) SOMATULINE DEPOT (34) PASIREOTIDE DIASPARTATE (22) BROMOCRIPTINE (19)

Related Pages

CANAKINUMAB Full Profile All Acromegaly Drugs CANAKINUMAB Demographics CANAKINUMAB Timeline